Skip to main content

Animations

MJFF Publications

4191 - 4200 of 6324 Results
Title
Year
  • Year
  • 2017
  • 2018
  • 2023
  • 2014
  • 2018
  • 2018
  • 2017
  • 2020
  • 2021
  • 2024
  • Summary Details
    OPEN
    Title: Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study
    Journal Name: Schizophrenia Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.schres.2017.11.038
    Citation Count: 80
  • Summary Details
    OPEN
    Title: High complement levels in astrocyte‐derived exosomes of Alzheimer disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25172
    Citation Count: 314
  • Summary Details
    OPEN
    Title: Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00109-6
    Citation Count: 465
  • Summary Details
    OPEN
    Title: Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer’s disease brains and human microglia
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.09.052
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer’s Disease Not Evident in Mouse Models
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.celrep.2017.12.066
    Citation Count: 587
  • Summary Details
    OPEN
    Title: LRRK2 activation in idiopathic Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5429
    Citation Count: 547
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.27232
    Citation Count: 138
  • Summary Details
    OPEN
    Title: A Parkinson's disease Circ RNA s Resource reveals a link between circ SLC 8A1 and oxidative stress
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.201911942
    Citation Count: 120
  • Summary Details
    OPEN
    Title: Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-021-02367-3
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Long-Term Dementia Risk in Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000209699
    Citation Count: 21
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.